Browse the corpus

REFERENCES Au WY, Tam S, Fong BM, et al, "Determinants of Cerebrospinal Fluid Arsenic Concentration in Patients With Acute Promyelocytic Leukemia on Oral Arsenic Trioxide Therapy," Blood , 2008, 112(9):3587-90. [PubMed 18703707 ] Concha G, Vogler G, Lezcano D, et al, "Exposure to Inorganic Arsenic Metabolites During Early Human Development," Toxicol Sci , 1998, 44(2):185-90. [PubMed 9742656 ] "Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc," Food and Nutrition Board, Institute of Medicine. National Academy of Sciences, Washington, DC: National Academy Press, 2001, 162-84. Fox E, Razzouk BI, Widemann BC, et al, "Phase 1 Trial and Pharmacokinetic Study of Arsenic Trioxide in Children and Adolescents With Refractory or Relapsed Acute Leukemia, Including Acute Promyelocytic Leukemia or Lymphoma," Blood , 2008, 111(2):566-73. [PubMed 17959855 ] Gore SD, Gojo I, Sekeres MA, et al, "Single Cycle of Arsenic Trioxide-Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia," J Clin Oncol , 2010, 28(6):1047-53. [PubMed 20085935 ] Mathews V, George B, Chendamarai E, et al, "Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data," J Clin Oncol , 2010, 28(24):3866-71. [PubMed 20644086 ] Mathews V, George B, Lakshmi KM, et al, "Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Durable Remissions With Minimal Toxicity," Blood , 2006, 107(7):2627-32. [PubMed 16352810 ] National Comprehensive Cancer Network® (NCCN), "Practice Guidelines in Oncology: Acute Myeloid Leukemia, Version 3, 2010." Available at file://www.nccn.org/professionals/physician_gls/PDF/aml.pdf National Institute for Occupational Safety and Health (NIOSH), "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012." Available at file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf . Accessed January 21, 2013. Powell BL, Moser B, Stock W, et al, "Arsenic Trioxide Improves Event-Free and Over-All Survival for Adults With Acute Promyelocytic Leukemia: North American Leukemia Intergroup Study C9710," Blood , 2010, 116(19):3751-7. [PubMed 20705755 ]

National Institute for Occupational Safety and Health (NIOSH), "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012." Available at file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf . Accessed January 21, 2013. Powell BL, Moser B, Stock W, et al, "Arsenic Trioxide Improves Event-Free and Over-All Survival for Adults With Acute Promyelocytic Leukemia: North American Leukemia Intergroup Study C9710," Blood , 2010, 116(19):3751-7. [PubMed 20705755 ] Powell BL, Moser B, Stock W, et al, "Effect of Consolidation With Arsenic Trioxide (As2O3) on Event-Free Survival (EFS) and Overall Survival (OS) Among Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL): North American Intergroup Protocol C9710," J Clin Oncol , 2007, 25(18s):2 [abstract 2 from 2007 ASCO Annual Meeting]. Ravandi F, Estey E, Jones D, et al, "Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin," J Clin Oncol , 2009, 27(4):504-10. [PubMed 19075265 ] Von Ehrenstein OS, Guha Mazumder DN, Hira-Smith M, et al, "Pregnancy Outcomes, Infant Mortality, and Arsenic in Drinking Water in West Bengal, India," Am J Epidemiol , 2006,163(7):662-9. [PubMed 16651647 ] Yang CY, Chang CC, Tsai SS, et al, "Arsenic in Drinking Water and Adverse Pregnancy Outcome in an Arseniasis-Endemic Area in Northeastern Taiwan," Environ Res , 2003, 91(1):29-34. [PubMed 12550085 ] Topic 16769 Version 19.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1102-61.234.146.186-71903B288C-S244013.14]